Sarah Dolman

Sarah Dolman is currently a SBIR / STTR Panelist and Reviewer at NSF, a Partner at Recon Strategy, a Mentor at Endless Frontier Labs, a Board Member at NanoPharmaSolutions, Inc., and an Independent Consultant for Biotech & Healthtech Startups at Healthtech Catalyst. Sarah has a background in healthcare consulting, strategic initiatives, business operations, and research and development within the pharmaceutical industry. Sarah holds a Ph.D. in Organic Chemistry from Massachusetts Institute of Technology, an MBA in Strategy and Leadership & Change Management from NYU Stern School of Business, and an Hon. B.Sc. in Chemistry & Mathematics from the University of Toronto.